Dr. Jimbo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1015 Walnut St
Curtis 1100
Philadelphia, PA 19107Phone+1 507-266-9968Fax+1 507-284-4951
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Urology, 2018 - 2022
- Mayo Clinic College of Medicine and Science (Rochester)Internship, Surgery, 2017 - 2018
- Jefferson College of Biomedical SciencesPhD, Cell and Developmental Biology, 2008 - 2017
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2017
- University of PennsylvaniaMS, Chemistry, 2007 - 2008
- University of PennsylvaniaBA, Biochemistry, Magna Cum Laude, 2003 - 2007
Certifications & Licensure
- ND State Medical License 2023 - 2026
- UT State Medical License 2022 - 2026
- NJ State Medical License 2024 - 2025
- PA State Medical License 2024 - 2024
- MN State Medical License 2017 - 2022
Awards, Honors, & Recognition
- The Michael Grasso, M.D. Prize in Urology Thomas Jefferson University, 2017
- The Yun Yen, M.D., Ph.D. and Sophie Yen Thesis Prize for Distinguished Research in Pathobiology Thomas Jefferson University, 2017
- Alpha Omega Alpha Alpha Omega Alpha Honor Medical Society, 2016
- Join now to see all
Publications & Presentations
PubMed
- 14 citationsFertility in the aging male: a systematic review.Masaya Jimbo, Jason Kunisaki, Mohammadali Ghaed, Victor Yu, Hunter A Flores
Fertility and Sterility. 2022-12-01 - 288 citationsAnalysis of 13 cell types reveals evidence for the expression of numerous novel primate- And tissue-specific microRNAsEric Londina, Phillipe Lohera, Aristeidis G. Telonis, Kevin Quann, Peter Clark
Proceedings of the National Academy of Sciences of the United States of America. 2015-03-10 - 75 citationsPosttranscriptional Upregulation of IDH1 by HuR Establishes a Powerful Survival Phenotype in Pancreatic Cancer CellsMahsa Zarei, Shruti Lal, Seth J. Parker, Avinoam Nevler, Ali Vaziri-Gohar
Cancer Research. 2017-08-15
Journal Articles
- Neoadjuvant chemotherapy and Appleby procedure for pancreatic acinar cell carcinoma: A case report.Jimbo M, Batista PM, Baliff JP, Yeo CJ, Case Reports in Pancreatic Cancer
Abstracts/Posters
- A personalized approach to adjuvant therapy: Cytoplasmic HuR status predicts disease-free survival after resection for pancreatic ductal adenocarcinoma.Tatarian T, Grigoli A, Leiby BE, Jimbo M, Dabbish N, Jiang W, Neoptolemos JP, Greenhalf W, Costello E, Ghaneh P, Palmer D, Buchler M, Yeo CJ, Winter JM, Brody JR, Pancreas Club, San Diego, CA, USA, 5/20/2016
- The RNA-binding protein HuR facilitates proliferation and metastasis in human pancreatic ductal adenocarcinoma.Jimbo M, Blanco FF, Screnci B, Cosma G, Alexeev V, Huang Y, Winter JM, Yeo CJ, Sawicki JA, Brody JR, American Association for Cancer Research (AACR) Annual Meeting, Philadelphia, PA, USA, 4/22/2015
- Targeting tumor-associated hypoxia to overcome chemoresistance in pancreatic ductal adenocarcinoma (PDA).Blanco FF, Jimbo M, Enyenihi L, Meisner-Kober N, Londin E, Rigoutsos I, Risbud MV, McCue P, Yeo CJ, Winter JM, Brody JR, American Association for Cancer Research (AACR) Annual Meeting, Philadelphia, PA, USA, 4/20/2015
- Join now to see all
Professional Memberships
- Alpha Omega Alpha Honor Medical SocietyMember
- American Urological AssociationMember
Other Languages
- Japanese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: